Standard treatment for metastatic colorectal cancer (CRC)

被引：0
|
作者：
Van Cutsem, Eric [1 ]
Tejpar, Sabine [1 ]
Verslype, Chris [1 ]
机构：
[1] Univ Hosp Gasthuisberg, Digest Oncol Unit, Louvain, Belgium
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [1] Oral capecitabine in metastatic colorectal cancer (CRC)
    Basu, B
    Abraham, J
    Bulusu, VR
    Grant, K
    Corcoran, M
    Shaw, J
    Harris, R
    Corrie, P
    Wilson, CB
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 : S47 - S47
  • [2] Prognosis, prediction and treatment evaluation during chemotherapy for metastatic colorectal cancer (CRC)
    Bystrom, P.
    Berglund, A.
    Frodin, J.
    Nygren, P.
    Glimellus, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : VII27 - VII27
  • [3] Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
    Holch, Julian
    Stintzing, Sebastian
    Heinemann, Volker
    [J]. VISCERAL MEDICINE, 2016, 32 (03) : 178 - 183
  • [4] Globo H expression in metastatic colorectal cancer (CRC).
    Jayachandran, Priya
    Baca, Yasmine
    Xiu, Joanne
    Zhang, Jian
    Battaglin, Francesca
    Arai, Hiroyuki
    Goldberg, Richard M.
    Weinberg, Benjamin Adam
    Lou, Emil
    Hall, Michael J.
    Khushman, Moh'd M.
    Sohal, Davendra
    Soni, Shivani
    Wang, Jingyuan
    Zhang, Wu
    Millstein, Joshua
    Korn, Wolfgang Michael
    Lenz, Heinz-Josef
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
    Berretta, Massimiliano
    Zanet, Ernesto
    Nasti, Guglielmo
    Lleshi, Arben
    Frustaci, Sergio
    Fiorica, Francesco
    Bearz, Alessandra
    Talamini, Renato
    Lestuzzi, Chiara
    Lazzarini, Renzo
    Fisichella, Rossella
    Cannizzaro, Renato
    Iaffaioli, Rosario Vincenzo
    Berretta, Salvatore
    Tirelli, Umberto
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2012, 55 (02) : 271 - 275
  • [6] Racial disparities and the outcome of metastatic (met) colorectal cancer (CRC).
    Barzi, Afsaneh
    Shabihkhani, Maryam
    Yu, Steven
    Yang, Dongyun
    Ji, Lingyun
    Lenz, Heinz-Josef
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [7] Consensus molecular subtypes (CMS) as a marker for treatment and disease biology in metastatic colorectal cancer (CRC).
    Lam, Michael
    Marie, Preeti Kanikarla
    Sarshekeh, Amir Mehrvarz
    Morris, Van K.
    Duose, Dzifa Yawa
    Zhang, BaiLi
    Chen, Huiqin
    Morris, Jeffrey
    Mehta, Trupti R.
    Katkhuda, Riham
    Kopetz, Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] The introduction of bevacizumab for the treatment of metastatic colorectal cancer (CRC) in Ontario and its effect on hepatic metastectomy
    Leeper, William Robert
    Chang, Hector Hugo Li
    Welch, Stephen
    Driman, David K.
    Quan, Douglas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] Overall survival and treatment patterns in patients with metastatic colorectal cancer (CRC): A retrospective chart review
    Sugrue, D.
    Gordon, J.
    Nassar, A.
    Hartridge-Lambert, S.
    Kayhanian, H.
    Ryan, A.
    Joharatnam-Hogan, N.
    Rodriguez-Justo, M.
    Shiu, K.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S257 - S257
  • [10] Metastatic colorectal cancer: Is there one standard approach?
    Saltz, Leonard B.
    [J]. ONCOLOGY-NEW YORK, 2005, 19 (09): : 1147 - 1154
12345